[(3S,4R)-3-[(R)-1-(tert-Butyl-dimethyl-silanyloxy)-ethyl]-2-oxo-4-((R)-2-oxo-cyclohexyl)-azetidin-1-yl]-oxo-acetic acid allyl ester | 136279-85-1

• 分子结构分类: 有机化合物 - 有机杂环化合物 - 内酰胺类
• 英文名称: [(3S,4R)-3-[(R)-1-(tert-Butyl-dimethyl-silanyloxy)-ethyl]-2-oxo-4-((R)-2-oxo-cyclohexyl)-azetidin-1-yl]-oxo-acetic acid allyl ester
• 英文别名: prop-2-enyl 2-[(3S,4R)-3-[(1R)-1-[tert-butyl(dimethyl)silyl]oxyethyl]-2-oxo-4-[(1R)-2-oxocyclohexyl]azetidin-1-yl]-2-oxoacetate
• CAS: 136279-85-1
• 化学式: C₂₂H₃₅NO₆Si
• 分子量: 437.608
• InChiKey: XSYWYWNOEKVUFR-CYGHRXIMSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  3.24
• 重原子数：
  30
• 可旋转键数：
  9
• 环数：
  2.0
• sp3杂化的碳原子比例：
  0.73
• 拓扑面积：
  90
• 氢给体数：
  0
• 氢受体数：
  6

反应信息

• 作为反应物：
  描述：

  [(3S,4R)-3-[(R)-1-(tert-Butyl-dimethyl-silanyloxy)-ethyl]-2-oxo-4-((R)-2-oxo-cyclohexyl)-azetidin-1-yl]-oxo-acetic acid allyl ester 在 四丁基氟化铵 、 溶剂黄146 、 对苯二酚 、 亚磷酸三乙酯 作用下， 以 四氢呋喃 、 甲苯 为溶剂， 生成 allyl (5S,6R,7R)-5-[(R)-1-hydroxyethyl]-4-oxo-3-azatricyclo[5.4.0.03,6 ]undec-1-ene-2-carboxylate
  参考文献：
  名称：

  Design, synthesis and bioactivity evaluation of tribactam β lactamase inhibitors

  摘要：

  Known carbapenem compounds with inhibitory effect towards P-lactamase enzymes are formed from bicyclical beta lactam structural scaffolds. On the basis of results from theoretical computational methods and molecular modelling we have designed and developed a synthetic route towards novel, biologically active tricyclic derivatives of carbapenems. (C) 2002 Elsevier Science Ltd. All rights reserved.

  DOI：

  10.1016/s0960-894x(02)00061-6
• 作为产物：
  描述：

  4-乙酰氧基氮杂环丁酮 在 甲酸 四(三苯基膦)钯 、 sodium hydride 、 三乙胺 、 三苯基膦 作用下， 以 四氢呋喃 、 二氯甲烷 为溶剂， 生成 [(3S,4R)-3-[(R)-1-(tert-Butyl-dimethyl-silanyloxy)-ethyl]-2-oxo-4-((R)-2-oxo-cyclohexyl)-azetidin-1-yl]-oxo-acetic acid allyl ester
  参考文献：
  名称：

  Design, synthesis and bioactivity evaluation of tribactam β lactamase inhibitors

  摘要：

  Known carbapenem compounds with inhibitory effect towards P-lactamase enzymes are formed from bicyclical beta lactam structural scaffolds. On the basis of results from theoretical computational methods and molecular modelling we have designed and developed a synthetic route towards novel, biologically active tricyclic derivatives of carbapenems. (C) 2002 Elsevier Science Ltd. All rights reserved.

  DOI：

  10.1016/s0960-894x(02)00061-6